1315 related articles for article (PubMed ID: 18405785)
1. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.
Barrons R; Tassone D
Clin Ther; 2008 Mar; 30(3):453-68. PubMed ID: 18405785
[TBL] [Abstract][Full Text] [Related]
2. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
Larsson PG; Stray-Pedersen B; Ryttig KR; Larsen S
BMC Womens Health; 2008 Jan; 8():3. PubMed ID: 18197974
[TBL] [Abstract][Full Text] [Related]
3. Targeting the vaginal microbiota with probiotics as a means to counteract infections.
Reid G; Dols J; Miller W
Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):583-7. PubMed ID: 19741517
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis.
Mastromarino P; Macchia S; Meggiorini L; Trinchieri V; Mosca L; Perluigi M; Midulla C
Clin Microbiol Infect; 2009 Jan; 15(1):67-74. PubMed ID: 19046169
[TBL] [Abstract][Full Text] [Related]
5. A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules.
Eriksson K; Carlsson B; Forsum U; Larsson PG
Acta Derm Venereol; 2005; 85(1):42-6. PubMed ID: 15848990
[TBL] [Abstract][Full Text] [Related]
6. Probiotics in the prevention of recurrences of bacterial vaginosis.
Parma M; Stella Vanni V; Bertini M; Candiani M
Altern Ther Health Med; 2014; 20 Suppl 1():52-7. PubMed ID: 24473986
[TBL] [Abstract][Full Text] [Related]
7. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells.
Zárate G; Nader-Macias ME
Lett Appl Microbiol; 2006 Aug; 43(2):174-80. PubMed ID: 16869901
[TBL] [Abstract][Full Text] [Related]
8. The role of lactobacillus probiotics in the treatment or prevention of urogenital infections--a systematic review.
Abad CL; Safdar N
J Chemother; 2009 Jun; 21(3):243-52. PubMed ID: 19567343
[TBL] [Abstract][Full Text] [Related]
9. Microecology, bacterial vaginosis and probiotics: perspectives for bacteriotherapy.
Famularo G; Perluigi M; Coccia R; Mastroiacovo P; De Simone C
Med Hypotheses; 2001 Apr; 56(4):421-30. PubMed ID: 11339841
[TBL] [Abstract][Full Text] [Related]
10. Probiotics: potential to prevent HIV and sexually transmitted infections in women.
Bolton M; van der Straten A; Cohen CR
Sex Transm Dis; 2008 Mar; 35(3):214-25. PubMed ID: 18490864
[TBL] [Abstract][Full Text] [Related]
11. The role of lactobacilli and probiotics in maintaining vaginal health.
Borges S; Silva J; Teixeira P
Arch Gynecol Obstet; 2014 Mar; 289(3):479-89. PubMed ID: 24170161
[TBL] [Abstract][Full Text] [Related]
12. Could probiotics be an option for treating and preventing urogenital infections?
Reid G; Bruce AW
Medscape Womens Health; 2001 Oct; 6(5):9. PubMed ID: 11698931
[TBL] [Abstract][Full Text] [Related]
13. Probiotic strategies for the treatment and prevention of bacterial vaginosis.
MacPhee RA; Hummelen R; Bisanz JE; Miller WL; Reid G
Expert Opin Pharmacother; 2010 Dec; 11(18):2985-95. PubMed ID: 21080853
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of vaginal lactobacilli by a bacteriocin-like inhibitor produced by Enterococcus faecium 62-6: potential significance for bacterial vaginosis.
Kelly MC; Mequio MJ; Pybus V
Infect Dis Obstet Gynecol; 2003; 11(3):147-56. PubMed ID: 15022875
[TBL] [Abstract][Full Text] [Related]
15. [Non-antibiotic prophylaxis for recurrent urinary-tract infections].
Beerepoot MA; ter Riet G; Verbon A; Nys S; de Reijke TM; Geerlings SE
Ned Tijdschr Geneeskd; 2006 Mar; 150(10):541-4. PubMed ID: 16566416
[TBL] [Abstract][Full Text] [Related]
16. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
[TBL] [Abstract][Full Text] [Related]
17. Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial.
Parent D; Bossens M; Bayot D; Kirkpatrick C; Graf F; Wilkinson FE; Kaiser RR
Arzneimittelforschung; 1996 Jan; 46(1):68-73. PubMed ID: 8821521
[TBL] [Abstract][Full Text] [Related]
18. Effect of lactobacilli administration in the vaginal tract of mice: evaluation of side effects and local immune response by local administration of selected strains.
Vintiñi E; Ocaña V; Elena Nader-Macías M
Methods Mol Biol; 2004; 268():401-10. PubMed ID: 15156050
[TBL] [Abstract][Full Text] [Related]
19. Disruption of urogenital biofilms by lactobacilli.
McMillan A; Dell M; Zellar MP; Cribby S; Martz S; Hong E; Fu J; Abbas A; Dang T; Miller W; Reid G
Colloids Surf B Biointerfaces; 2011 Aug; 86(1):58-64. PubMed ID: 21497071
[TBL] [Abstract][Full Text] [Related]
20. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy.
Donders GG; Van Calsteren K; Bellen G; Reybrouck R; Van den Bosch T; Riphagen I; Van Lierde S
BJOG; 2009 Sep; 116(10):1315-24. PubMed ID: 19538417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
